Therapeutic advancement in inflammatory bowel disease by incorporating plant-based diet

被引:0
|
作者
Chiba, Mitsuro [1 ]
Tsuji, Tsuyotoshi [1 ]
Komatsu, Masafumi [1 ]
机构
[1] Akita City Hosp, Div Gastroenterol, Akita, Japan
关键词
Crohn's disease ( CD); inflammatory bowel disease (IBD); ulcerative colitis (UC); plant-based diet; (PBD); infliximab;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Identification and recognition of the ubiquitous environmental factor are prerequisite for treatment and prevention of the disease. The biggest problem with current practice in inflammatory bowel disease (IBD) is the lack of a widely appreciated ubiquitous environmental factor for the disease. The incidence of IBD is associated with dietary transition from a traditional diet to the current (westernized) diet. Prospective cohort studies and case-control studies indicate that the current diet is a risk factor for IBD. The current diet tends to cause gut microbial dysbiosis resulting in a pro-inflammatory state. Therefore, we regard our current diet as this factor. Even nutritionally balanced meals are unable to suppress relapse, particularly in Crohn's disease (CD). Therefore, we developed a plant-based diet (PBD) ( lacto- ovo-semivegetarian diet) to counter the current diet. By incorporating the PBD into practice, we achieved far better outcomes in both ulcerative colitis (UC) and CD in both the induction and quiescent phases compared to the current standard therapy. All patients were treated on an inpatient basis and provided with a PBD. CD is far more untenable than UC and is destined to follow a disabling course. Therefore, infliximab was indicated in all patients with CD, but only in severe cases with UC. This infliximab and PBD as first-line (IPF) therapy broke the barrier of primary nonresponders to biologics (around 30%): the remission rate was 96% (44/46) in CD and 76% (13/17) in severe UC. A PBD can induce remission without medication in approximately one-third of mild cases of UC. All patients were advised to adhere PBD after discharge. In CD, a relapsefree outcome was achieved in nearly a half of patients (52%) at 10-year follow-up without biologics or immunosuppressants. Cumulative relapse rates for 51 initial episode cases of UC (18 mild, 30 moderate, 3 severe) at 1 and 5 years were 14% and 27%, respectively. We believe our assertion that the current diet is the ubiquitous environmental factor underlying IBD is correct and a PBD is right diet for the disease.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Therapeutic advancement in inflammatory bowel disease by incorporating plant-based diet
    Chiba, Mitsuro
    Tsuji, Tsuyotoshi
    Komatsu, Masafumi
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 8
  • [2] Plant-Based Diet Recommended for Inflammatory Bowel Disease
    Chiba, Mitsuro
    Hosoba, Mihoko
    Yamada, Koko
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (05) : e17 - e18
  • [3] Reply: Plant-Based Diet Recommended for Inflammatory Bowel Disease
    Limketkai, Berkeley N.
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (05) : e19 - e19
  • [4] Incorporation of Plant-Based Diet Surpasses Current Standards in Therapeutic Outcomes in Inflammatory Bowel Disease
    Chiba, Mitsuro
    Morita, Norikazu
    METABOLITES, 2023, 13 (03)
  • [5] Plant-based diet for pregnant women with inflammatory bowel disease: case series
    Chiba, Mitsuro
    Fukuda, Jun
    Izumiya, Yuki
    Sugawara, Kae
    Tsuji, Tsuyotoshi
    Tozawa, Haruhiko
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9
  • [6] How to Optimize Effects of Infliximab in Inflammatory Bowel Disease: Incorporation of a Plant-Based Diet
    Aden, Konrad
    Schreiber, Stefan
    Rosenstiel, Philip
    GASTROENTEROLOGY, 2020, 158 (05) : 1512 - 1513
  • [7] Recommendation of plant-based diets for inflammatory bowel disease
    Chiba, Mitsuro
    Ishii, Hajime
    Komatsu, Masafumi
    TRANSLATIONAL PEDIATRICS, 2019, 8 (01) : 23 - 27
  • [8] Plant-based Diets for Inflammatory Bowel Disease: What Is the Evidence?
    Liu, Gordon X. H.
    Day, Andrew S.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (10) : 1865 - 1876
  • [9] The role of a plant-based diet in the pathogenesis, etiology and management of the inflammatory bowel diseases
    Grosse, Charlene S. J.
    Christophersen, Claus T.
    Devine, Amanda
    Lawrance, Ian C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (03) : 137 - 145
  • [10] Medicinal plant-based drug delivery system for inflammatory bowel disease
    Li, Ningcen
    Wang, Meijuan
    Lyu, Zhongxi
    Shan, Kai
    Chen, Zelin
    Chen, Bo
    Chen, Yong
    Hu, Xiyou
    Dou, Baomin
    Zhang, Jingyu
    Wang, Lifen
    Zhao, Tianyi
    Li, Hongjiao
    FRONTIERS IN PHARMACOLOGY, 2023, 14